Connection

Kent Armeson to Treatment Outcome

This is a "connection" page, showing publications Kent Armeson has written about Treatment Outcome.
Connection Strength

0.082
  1. Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
    View in: PubMed
    Score: 0.021
  2. Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention. Breast Cancer Res Treat. 2019 Feb; 173(3):559-571.
    View in: PubMed
    Score: 0.017
  3. Swallowing Outcomes in Elderly Patients following Microvascular Reconstruction of the Head and Neck. Otolaryngol Head Neck Surg. 2018 08; 159(2):320-327.
    View in: PubMed
    Score: 0.017
  4. Impact of group motivational interviewing on enhancing treatment engagement for homeless Veterans with nicotine dependence and other substance use disorders: A pilot investigation. Am J Addict. 2016 10; 25(7):533-41.
    View in: PubMed
    Score: 0.015
  5. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors. Cancer. 2013 Sep 15; 119(18):3385-92.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.